About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ulcerative Colitis Clinical Trials | 456 Studies Recruiting

Clinical TrialsUlcerative Colitis

Ulcerative Colitis Clinical Trials

Browse 456 clinical trials for ulcerative colitis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 456 trials

TerminatedLong Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)Primary Objective: To assess the long term safety and tolerability of SAR339658 Secondary Objective: To assess the long term efficacy of SAR339658NCT01861249·Mission Hills, California and 4 others UnknownEfficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat SyndromeUlcerative colitis(UC) seriously affect the quality of life in patients.NCT04057547·Beijing, Beijing Municipality RecruitingSelenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced TherapiesMicronutrient deficiencies are common in ulcerative colitis (UC). Selenium deficiency is associated with worse disease outcomes including disease flares and need for surgery.NCT07427017·Chicago, Illinois

Related Searches

Data from ClinicalTrials.govTerms

CompletedCT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)This is Phase 3, Randomized, Placebo-controlled study to demonstrate superiority of CT-P13 SC over Placebo SC in Patients With Moderately to Severely Active Ulcerative ColitisNCT04205643·Warsaw

Not yet recruitingVR Therapies for IBDThrough a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT)…NCT07590518·Los Angeles, California and 1 other

CompletedVedAryo® (Vedolizumab) Effectiveness and Safety EvaluationThe aim of this observational study is to evaluate Effectiveness and safety of VedAryo® (Vedolizumab) in male or female participants with clinical diagnosis of Inflammatory Bowel…NCT07273760·Shiraz, Fars and 11 others

RecruitingTailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with…NCT06784323·Miami, Florida

CompletedCharacterization of CD Responders to VedolizumabThe purpose of this study is to characterize which patients with Crohn's disease are likely to respond to standard of care to vedolizumab therapy.NCT04909359·Miami, Florida

RecruitingStudy to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative ColitisThe study is to evaluate the safety, feasibility, and preliminary efficacy of frozen FMT delivery via retention enema compared to lyophilized powder given in oral capsules as…NCT05786404·Houston, Texas

CompletedSupplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis DThis study aims to evaluate the effect of vitamin D3 supplementation on disease activity and quality of life in IBD patients deficient in vitamin D, and also help determine the…NCT01877577·Fresno, California

Not yet recruitingUpadacitinib in Patients Hospitalized With Acute Severe Ulcerative ColitisThe goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are…NCT07502339·San Francisco, California

TerminatedEvaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative ColitisThis is a randomized, double blind, placebo-controlled, parallel group multi-center study in adult participants with active moderate to severe UC.NCT01671956·Afula and 5 others

UnknownDynamic Changes of Gut Microbiota in UC After FMTA prospective study to investigate the dynamic changes of gut microbiota through colonic transendoscopic enteral tubing in patients with ulcerative colitis after fecal microbiota…NCT03949257·Nanjing, Jiangsu

CompletedOpen-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyThe objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative…NCT00486031·Birmingham, Alabama and 94 others

RecruitingND-12 Combined With H-6 for Adult Chronic Inflammatory DiarrheaThis is a randomized controlled trial to explore the efficacy and safety of ND-12 combined with H-6 for patients with chronic inflammatory diarrheaNCT07767370·Nanjing, Jiangsu

CompletedStudy of Cimzia for the Treatment of Ulcerative ColitisThe purpose of this study is to determine if Cimzia (certolizumab pegol) is an effective treatment for patients with Ulcerative colitis.NCT01090154·Philadelphia, Pennsylvania and 1 other

Active not recruitingMulti-Center African-American Inflammatory Bowel Disease Study (MAAIS)The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population.NCT01169194·Baltimore, Maryland

CompletedImpact of the Novel UC-TREAT Diet on the Gut Microbiome and Its Acceptability in Healthy Adults and Adults With Quiescent Ulcerative ColitisThis will be an open-label dietary intervention study recruiting both healthy adults (≥16y) and adults with quiescent Ulcerative Colitis (UC).NCT06998277·Glasgow

CompletedAssessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative ColitisConsequences of latent cytomegalovirus (CMV) infection reactivation on ulcerative colitis flare, as a flare-worsening factor or simple bystander, are debated.NCT02439372·Seoul

UnknownUtilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)Ulcerative colitis (UC) is a chronic inflammatory condition of unknown aetiology, characterized by a diffuse confluent mucosal inflammation of the colon starting from the rectum…NCT02049775·Leeds

PreviousPage 18 of 23Next